JP Maianti is an Assistant Professor at The Albert Einstein College of Medicine and The Montefiore Einstein Comprehensive Cancer Center. Prior to joining Einstein, he co-founded and worked at Exo Therapeutics Inc, a startup company spun off from his PhD and postdoctoral research at Harvard on targeting enzyme exo-sites, instead of catalytic sites, to achieve specificity and substrate-selective inhibition.